Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis
- PMID: 1061097
- PMCID: PMC388890
- DOI: 10.1073/pnas.72.12.5130
Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis
Abstract
Lesional epidermis of psoriasis has a probable reduction in the cyclic AMP/cyclic GMP ratio. This altered ratio may in part be responsible for the characteristic glycogen storage, rapid cell proliferation, and reduced differentiation in lesional epidermis. The concentrations of prostaglandins E2 and F2alpha, free arachidonic acid, and 12L-hydroxy-5,8,10,14-eicosatetrawnoic acid in specimens of uninvolved and involved epidermis of psoriasis were measured with deuterium-labeled carriers and multiple ion analysis. Snap frozen specimens contained: 1.4 +/- 0.4 mug/g (wet weight) of arachidonic acid in uninvolved in contrast to 36.3 +/- 16.7 mug/g in involved epidermis (P = 0.015); less than 0.05 +/- 0.01 mug/g of hydroxyeicosatetraenoic acid in uninvolved in contrast to 4.1 +/- 1.9 mug/g in involved epidermis (P = 0.015); 23.6 +/- 5.0 ng/g of prostaglandin E2 in uninvolved in contrast to 33.1 +/- 5.7 ng/g in involved epidermis (P less than 0.01); and 21.0 +/- 4.4 ng/g of prostaglandin F2alpha in uninvolved in contrast to 39.0 +/- 5.9 ng/g in involved epidermis (P less than 0.01). The arachidonic acid and hydroxyeicosatetraenoic acid levels in involved epidermis were strongly correlated (r = 0.97). The increased levels of arachidonic acid and 12L-hydroxy-5,8,10,14-eicosatetraenoic acid in involved epidermis may have diagnostic and pathophysiological importance.
Similar articles
-
Prostaglandins E2, F2alpha and arachidonic acid levels in irradiated and unirradiated skin of psoriatic patients receiving PUVA treatment.Clin Exp Dermatol. 1978 Dec;3(4):367-9. doi: 10.1111/j.1365-2230.1978.tb01515.x. Clin Exp Dermatol. 1978. PMID: 737880 No abstract available.
-
Selective decrease of 15-hydroxyeicosatetraenoic acid (15-HETE) formation in uninvolved psoriatic dermis.Arch Dermatol. 1986 Aug;122(8):877-80. Arch Dermatol. 1986. PMID: 3090943
-
The analysis of arachidonic acid metabolites in normal, uninvolved and lesional psoriatic skin.Prostaglandins. 1984 Jul;28(1):57-65. doi: 10.1016/0090-6980(84)90113-8. Prostaglandins. 1984. PMID: 6435188
-
[Prostaglandin biosynthesis in psoriatic epidermis (author's transl)].Ann Dermatol Venereol. 1980;107(10):889-93. Ann Dermatol Venereol. 1980. PMID: 7015965 Review. French.
-
Cyclic nucleotides, prostaglandins and polyamines in psoriasis.Pharmacol Ther. 1980;9(3):297-310. doi: 10.1016/0163-7258(80)90021-2. Pharmacol Ther. 1980. PMID: 6251486 Review. No abstract available.
Cited by
-
Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.Br J Clin Pharmacol. 1986 Dec;22(6):627-32. doi: 10.1111/j.1365-2125.1986.tb02949.x. Br J Clin Pharmacol. 1986. PMID: 3032226 Free PMC article.
-
FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor.Agents Actions. 1990 Jun;30(3-4):432-42. doi: 10.1007/BF01966309. Agents Actions. 1990. PMID: 2117338
-
Biochemical and pharmacological properties of a new topical anti-inflammatory compound, 9-phenylnonanohydroxamic acid (BMY 30094).Agents Actions. 1990 Jun;30(3-4):443-50. doi: 10.1007/BF01966310. Agents Actions. 1990. PMID: 2117339
-
The metabolomics of psoriatic disease.Psoriasis (Auckl). 2017;7:1-15. doi: 10.2147/PTT.S118348. Epub 2017 Jan 31. Psoriasis (Auckl). 2017. PMID: 28824870 Free PMC article.
-
Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis.J Clin Invest. 1986 Jan;77(1):246-51. doi: 10.1172/JCI112283. J Clin Invest. 1986. PMID: 3080474 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources